ArticleImmuno-oncology technology2024

A novel anti-FGFR1 monoclonal antibody OM-RCA-01 exhibits potent antitumor activity and enhances the efficacy of immune checkpoint inhibitors in lung cancer models.

I Tsimafeyeu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.